Enfermedad de Parkinson: fisiopatología y nuevos tratamientos
Mutua de Terrassa
Terrassa, EspañaPublicaciones en colaboración con investigadores/as de Mutua de Terrassa (7)
2024
-
Automatic Segmentation and Quantification of Nigrosome-1 Neuromelanin and Iron in MRI: A Candidate Biomarker for Parkinson's Disease
Journal of Magnetic Resonance Imaging, Vol. 60, Núm. 2, pp. 534-547
2019
-
Dynamic atlas-based segmentation and quantification of neuromelanin-rich brainstem structures in Parkinson disease
IEEE Transactions on Medical Imaging, Vol. 38, Núm. 3, pp. 813-823
2018
-
Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population
Neurobiology of Aging, Vol. 70, pp. 325.e1-325.e5
2016
2015
-
Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease
Movement Disorders, Vol. 30, Núm. 7, pp. 945-952
2013
-
Suicidal ideation in a European Huntington's disease population
Journal of Affective Disorders, Vol. 151, Núm. 1, pp. 248-258
2010
-
Efficacy and safety of pallidal stimulation in primary dystonia: Results of the Spanish multicentric study
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 81, Núm. 1, pp. 65-69